Clinical trial for the evaluation of the efficacy and safety of NAO on serum cholesterol
Not Applicable
Recruiting
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0003878
- Lead Sponsor
- Dynebio
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1) Male and female subject aged between 20 years and 75 years
2) Subjects with Serum total cholesterol 200~249mg/dl or LDL-cholesterol 130~170mg/dl
Exclusion Criteria
1) cholesterol medications within the past 3 months
2) Subjects who drinks alcohol more than 4 times per a week
3) Subjects with Gallbladder disease or gout, porphyrias
4) Subjects with CNS disorder (depressive disorder, schizophrenia, alcoholism, drug addiction)
5) Subjects with malnutrition
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total cholesterol;LDL-cholesterol;HDL-cholesterol;Triglyceride;Apolipoprotein A1;Apolipoprotein B;Lipoprotein (a);Atherogenic index;BMI(Body Mass Index)
- Secondary Outcome Measures
Name Time Method Adverse event;clinical lab;vital sign;body weight;electrocardiogram